Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

SODIUM VALPROATE WOCKHARDT SOLUTION FOR INJECTION OR INFUSION 100mg/ml

Approval Number

SIN15343P

Drug Name

SODIUM VALPROATE WOCKHARDT SOLUTION FOR INJECTION OR INFUSION 100mg/ml

Product Name

SODIUM VALPROATE WOCKHARDT SOLUTION FOR INJECTION OR INFUSION 100mg/ml

Approval Date

October 13, 2017

Registrant

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Licence Holder

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Regulatory Information

Registrant

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Licence Holder

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, SOLUTION

Route of Administration

INTRAVENOUS

Medical Information

ATC Code

N03AG01

ATC Item Name

valproic acid

Manufacturer Information

Pharmaceutical Manufacturer

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Manufacturers

CP PHARMACEUTICALS LIMITED

Active Ingredients

Ingredient Name

Sodium valproate

Strength

100.0mg/ml

Drug MonographValproic acid

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

SODIUM VALPROATE WOCKHARDT SOLUTION FOR INJECTION OR INFUSION 100mg/ml - HSA Approval | MedPath